| Product Code: ETC11626146 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Finland saw continued growth in colorectal cancer drug imports, with key suppliers being Germany, Netherlands, Denmark, Sweden, and the USA. The Herfindahl-Hirschman Index (HHI) indicated low market concentration, reflecting a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 was steady at 2.88%, with a slight uptick in the growth rate from 2023 to 2024 at 0.14%. This data suggests a stable and gradually expanding market for colorectal cancer drugs in Finland, driven by diverse sources of imports.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Finland Colorectal Cancer Drugs Therapeutic Market Overview |
3.1 Finland Country Macro Economic Indicators |
3.2 Finland Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Finland Colorectal Cancer Drugs Therapeutic Market - Industry Life Cycle |
3.4 Finland Colorectal Cancer Drugs Therapeutic Market - Porter's Five Forces |
3.5 Finland Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Finland Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Finland Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Finland Colorectal Cancer Drugs Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of colorectal cancer in Finland |
4.2.2 Advancements in drug research and development for colorectal cancer treatment |
4.2.3 Growing awareness about early detection and treatment options for colorectal cancer |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new drugs in Finland |
4.3.2 High cost of colorectal cancer drugs and therapies |
4.3.3 Limited access to specialized healthcare facilities in certain regions of Finland |
5 Finland Colorectal Cancer Drugs Therapeutic Market Trends |
6 Finland Colorectal Cancer Drugs Therapeutic Market, By Types |
6.1 Finland Colorectal Cancer Drugs Therapeutic Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Finland Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Finland Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.1.4 Finland Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.5 Finland Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Finland Colorectal Cancer Drugs Therapeutic Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Finland Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Finland Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.2.4 Finland Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.2.5 Finland Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.2.6 Finland Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Finland Colorectal Cancer Drugs Therapeutic Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Finland Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.3.3 Finland Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 Finland Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Finland Colorectal Cancer Drugs Therapeutic Market Import-Export Trade Statistics |
7.1 Finland Colorectal Cancer Drugs Therapeutic Market Export to Major Countries |
7.2 Finland Colorectal Cancer Drugs Therapeutic Market Imports from Major Countries |
8 Finland Colorectal Cancer Drugs Therapeutic Market Key Performance Indicators |
8.1 Survival rates of colorectal cancer patients in Finland |
8.2 Adoption rate of new colorectal cancer drugs in the market |
8.3 Number of clinical trials for colorectal cancer drugs conducted in Finland |
9 Finland Colorectal Cancer Drugs Therapeutic Market - Opportunity Assessment |
9.1 Finland Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Finland Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Finland Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Finland Colorectal Cancer Drugs Therapeutic Market - Competitive Landscape |
10.1 Finland Colorectal Cancer Drugs Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 Finland Colorectal Cancer Drugs Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |